Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
80.59
-1.08 (-1.32%)
Jun 8, 2026, 10:18 AM EDT - Market open
Medtronic Cash Flow Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 |
Net Income | 4,837 | 4,691 | 3,705 | 3,784 | 5,062 |
Depreciation & Amortization | 2,958 | 2,861 | 2,647 | 2,697 | 2,707 |
Stock-Based Compensation | 457 | 429 | 393 | 355 | 359 |
Other Adjustments | 501 | 117 | 526 | 170 | 107 |
Change in Receivables | -200 | -433 | -391 | -576 | -477 |
Changes in Inventories | -404 | -292 | -139 | -939 | -560 |
Changes in Accounts Payable | 46 | 209 | 391 | 696 | 213 |
Changes in Other Operating Activities | -865 | -538 | -345 | -148 | -65 |
Operating Cash Flow | 7,330 | 7,044 | 6,787 | 6,039 | 7,346 |
Operating Cash Flow Growth | 4.06% | 3.79% | 12.39% | -17.79% | 17.72% |
Capital Expenditures | -1,904 | -1,859 | -1,587 | -1,459 | -1,368 |
Purchases of Investments | -8,725 | -8,226 | -7,748 | -7,514 | -9,882 |
Proceeds from Sale of Investments | 8,105 | 8,495 | 7,441 | 7,343 | 9,692 |
Payments for Business Acquisitions | -406 | -98 | -211 | -1,867 | -91 |
Other Investing Activities | -4 | -249 | -261 | 4 | -10 |
Investing Cash Flow | -2,934 | -1,937 | -2,366 | -3,493 | -1,659 |
Short-Term Debt Issued | - | - | - | 2,284 | - |
Short-Term Debt Repaid | - | - | - | -2,279 | - |
Net Short-Term Debt Issued (Repaid) | - | - | - | 5 | - |
Long-Term Debt Issued | 1,747 | 3,209 | - | 5,409 | - |
Long-Term Debt Repaid | -2,930 | - | - | -6,012 | -1 |
Net Long-Term Debt Issued (Repaid) | -1,183 | 3,209 | - | -603 | -1 |
Issuance of Common Stock | 516 | 508 | 284 | 308 | 429 |
Repurchase of Common Stock | -1,035 | -3,235 | -2,138 | -645 | -2,544 |
Net Common Stock Issued (Repurchased) | -519 | -2,727 | -1,854 | -337 | -2,115 |
Common Dividends Paid | -3,639 | -3,589 | -3,666 | -3,616 | -3,383 |
Other Financing Activities | 591 | -1,254 | 1,070 | -409 | 163 |
Financing Cash Flow | -4,751 | -4,361 | -4,450 | -4,960 | -5,336 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 85 | 188 | -230 | 243 | -231 |
Net Cash Flow | -269 | 934 | -259 | -2,171 | 121 |
Free Cash Flow | 5,426 | 5,185 | 5,200 | 4,580 | 5,978 |
Free Cash Flow Growth | 4.65% | -0.29% | 13.54% | -23.39% | 22.38% |
FCF Margin | 14.92% | 15.46% | 16.07% | 14.67% | 18.87% |
Free Cash Flow Per Share | 4.21 | 4.02 | 3.91 | 3.44 | 4.42 |
Levered Free Cash Flow | 3,449 | 8,252 | 4,643 | 4,007 | 5,965 |
Unlevered Free Cash Flow | 4,929 | 5,346 | 4,906 | 4,716 | 6,204 |